Home/Recalls/FDA-Z-2001-2026
FDA DevicesClass II

i-STAT G3+ cartridge; List Number: 03P78-26;

Published: May 6, 2026Recall ID: Z-2001-2026Category: devicesCountry: US

Reason for Recall / Hazard

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

Product Description & Identification

i-STAT G3+ cartridge; List Number: 03P78-26;

Affected Products

i-STAT G3+ cartridge; List Number: 03P78-26;

Additional Source Details

FieldValue
CityPrinceton
StateNJ
Event id98635
Address 1400 College Rd E
Code infoList Number: 03P78-26; UDI-DI: 00054749005673; Lot number: N25221;
Postal code08540-6607
Report date20260506
Product typeDevices
Product quantity40275 units (US only)
Reason for recallApproximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.
Voluntary mandatedVoluntary: Firm initiated
Recall initiation date20260401
Initial firm notificationLetter
Center classification date20260429

Overview

  • Recalling FirmAbbott Point Of Care Inc.
  • StatusOngoing
  • Risk LevelClass II
  • DistributionWorldwide distribution - US Nationwide and the countries of Canada, AUSTRIA, BANGLADESH, BELGIUM, FINLAND, FRANCE, GERMANY, IRELAND, ITALY, LUXEMBOURG, MAURITIUS, NETHERLANDS, NORWAY, POLAND, PORTUGAL, SPAIN, SWEDEN, SWITZERLAND, UNITED KINGDOM.
Official Agency Alert